InfuSystem Inc. (INFU)
5.48
-0.58 (-9.57%)
At close: Mar 28, 2025, 3:59 PM
5.54
1.09%
After-hours: Mar 28, 2025, 05:05 PM EDT
-9.57% (1D)
| Bid | 5.32 |
| Market Cap | 116.52M |
| Revenue (ttm) | 134.81M |
| Net Income (ttm) | 2.34M |
| EPS (ttm) | 0.11 |
| PE Ratio (ttm) | 49.82 |
| Forward PE | 41.75 |
| Analyst | n/a |
| Ask | 5.76 |
| Volume | 57,791 |
| Avg. Volume (20D) | 113,473 |
| Open | 6.06 |
| Previous Close | 6.06 |
| Day's Range | 5.45 - 5.92 |
| 52-Week Range | 5.29 - 9.97 |
| Beta | 1.76 |
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of va...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Dec 27, 2007
Employees 502
Stock Exchange AMEX
Ticker Symbol INFU
Website https://www.infusystem.com
Next Earnings Release
InfuSystem Inc. is scheduled to release its earnings on May 8, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+0.78%
InfuSystems shares are trading higher after the co...
Unlock content with
Pro Subscription
3 weeks ago · seekingalpha.com
InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call TranscriptInfuSystem Holdings, Inc. (NYSE:INFU ) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele -...
